OrthoPediatrics Corp (KIDS) stock
KIDSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/308% below fair value
$31.65+0.24 (+0.76%)
Close on Nov 18, 2026Market cap $826.40MP/E –Yield –
OrthoPediatrics total assets
Total assets on the balance sheet at the end of each period.
OrthoPediatrics's total assets was $509.09M at Sep 30, 2026. For fiscal 2025 it was $508.63M, up 7.5% from the year before. The highest annual figure on record is $508.63M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $508.63M | +7.5% |
| FY2024 | Dec 31, 2024 | $473.21M | +7.9% |
| FY2023 | Dec 31, 2023 | $438.75M | +2.6% |
| FY2022 | Dec 31, 2022 | $427.73M | +40.6% |
| FY2021 | Dec 31, 2021 | $304.27M | -5.0% |
| FY2020 | Dec 31, 2020 | $320.41M | +75.9% |
| FY2019 | Dec 31, 2019 | $182.15M | +62.5% |
| FY2018 | Dec 31, 2018 | $112.11M | +36.2% |
| FY2017 | Dec 31, 2017 | $82.30M | +168.3% |
| FY2016 | Dec 31, 2016 | $30.68M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $509.09M | +3.2% |
| Q2 FY2026 | Jun 30, 2026 | $511.39M | +1.5% |
| Q1 FY2026 | Mar 31, 2026 | $502.19M | +6.8% |
| Q4 FY2025 | Dec 31, 2025 | $508.63M | +7.5% |
| Q3 FY2025 | Sep 30, 2025 | $493.49M | +0.9% |
| Q2 FY2025 | Jun 30, 2025 | $503.61M | +16.9% |
| Q1 FY2025 | Mar 31, 2025 | $470.25M | +7.6% |
| Q4 FY2024 | Dec 31, 2024 | $473.21M | +7.9% |
| Q3 FY2024 | Sep 30, 2024 | $489.29M | +13.1% |
| Q2 FY2024 | Jun 30, 2024 | $430.76M | -0.9% |
| Q1 FY2024 | Mar 31, 2024 | $437.19M | +2.6% |
| Q4 FY2023 | Dec 31, 2023 | $438.75M | +2.6% |
| Q3 FY2023 | Sep 30, 2023 | $432.44M | +0.6% |
| Q2 FY2023 | Jun 30, 2023 | $434.87M | +31.4% |
| Q1 FY2023 | Mar 31, 2023 | $426.29M | +41.6% |
| Q4 FY2022 | Dec 31, 2022 | $427.73M | +40.6% |
| Q3 FY2022 | Sep 30, 2022 | $430.05M | +41.7% |
| Q2 FY2022 | Jun 30, 2022 | $330.94M | +7.6% |
| Q1 FY2022 | Mar 31, 2022 | $301.00M | -3.9% |
| Q4 FY2021 | Dec 31, 2021 | $304.27M | -5.0% |
| Q3 FY2021 | Sep 30, 2021 | $303.59M | -1.4% |
| Q2 FY2021 | Jun 30, 2021 | $307.66M | -6.3% |
| Q1 FY2021 | Mar 31, 2021 | $313.35M | +79.9% |
| Q4 FY2020 | Dec 31, 2020 | $320.41M | +75.9% |
| Q3 FY2020 | Sep 30, 2020 | $308.00M | +100.8% |
| Q2 FY2020 | Jun 30, 2020 | $328.49M | +116.9% |
| Q1 FY2020 | Mar 31, 2020 | $174.20M | +55.5% |
| Q4 FY2019 | Dec 31, 2019 | $182.15M | +62.5% |
| Q3 FY2019 | Sep 30, 2019 | $153.42M | +99.6% |
| Q2 FY2019 | Jun 30, 2019 | $151.43M | +94.5% |
| Q1 FY2019 | Mar 31, 2019 | $112.01M | +38.9% |
| Q4 FY2018 | Dec 31, 2018 | $112.11M | +36.2% |
| Q3 FY2018 | Sep 30, 2018 | $76.88M | +87.1% |
| Q2 FY2018 | Jun 30, 2018 | $77.85M | +153.8% |
| Q1 FY2018 | Mar 31, 2018 | $80.64M | – |
| Q4 FY2017 | Dec 31, 2017 | $82.30M | – |
| Q3 FY2017 | Sep 30, 2017 | $41.08M | – |
| Q4 FY2016 | Dec 31, 2016 | $30.68M | – |
See a number that looks wrong?